According to data provided by Ascri, in the first half of 2015, biotechnology, with 24 transactions, is the sector with the second highest number of transactions. In the last month, we have witnessed several operations for an amount equal to or greater than €10M.
M&A advisors with expertise in the technology sector
biotechnology
Latest Sectoral Reports |
Last Entries
Spanish biotech companies internationalise: Artax Biopharma, PharmaMar and Mind The Byte
In the last month we have seen how Spanish biotech companies are growing and opening up to new markets. Artax Biopharma has just received $10M from American investors, PharmaMar has started selling its product in Japan and Mind The Byte has just opened a subsidiary in Copehenague.
Biotech investment news September 2015: CaixaIpulse, Sanifit and Centauri Biotech
Good news for funding in the biotech sector in the first half of September, the largest round of funding in the history of Spanish biotechnology has been closed. CaixaImpulse has already announced its first 15 companies.
Biotechnology finds a new form of funding with Crowdfunding and Spain is one of the pioneers
Faced with the difficulty biotech companies have in finding both private and public funding, they are turning to crowdfunding. This year, Spain has created the first European platform and the second worldwide for biotech crowdfunding. Although the operations closed in Spain are still of a small amount, operations closed in biotechnology in other parts of the world, such as that of Cell Therapheutics for almost €1M, show that it is a form of financing that will eventually have a significant impact on the sector. In addition, the public sector has also launched a crowdfunding platform in the biotech sector.
CDTI's role in Spanish biotechnology
The CDTI is contributing to the development of biotechnology in our country. In the last half of 2014 alone, more than 40 biotechnology-related projects received CDTI funding. In addition, the Cdti also supports private funding and in May 2015 injected €5M in Inveready Innvierte Biotech II.
Biotechnology grows and finds alternative forms of financing
According to Asebio, the number of healthcare biotechnology projects developed in Spain grew by 30% in 2015, compared to the same period in 2014. These projects need funding and many of them are turning to alternative financing. Crowdfunding, public aid and venture capital funds are helping to make Spain a biotech country.
Biotech investment news: Era Biotech, Aura Bioscience, Quirumed and others (March 2015)
In March 2015 the biotechnology sector in Spain has been the protagonist of several investment operations, both venture capital and mergers and acquisitions of companies. Venture capital invests in biotech: Inveready, Ysios The investment...
Sendabio with the help of Abra Invest closes investment round
In April 2015, the Basque biotech company Sendabio has closed an investment round with an industrial partner. This capital injection will enable it to address its growth plan with the internationalisation of its products, initially in Latin America. Sendabio has been advised by Abra Invest for the successful completion of the operation.
Operations Biotechnology February 2015
February 2015 has been an active month for the Biotech sector. Spanish venture capital has carried out large deals in both Spanish and foreign companies. In addition, mergers and acquisitions have also taken place in the sector.
New developments in biotech funds in Spain (En-2015)
A small number of venture capitalists specialising in biotechnology are consolidating in Spain. Some of them are receiving support from international investors and others are emerging as a result of the attractiveness of Spain for this sector.
Analysis of the Internet of Things for Health
Accenture said in a report in 2011 that the healthcare sector would be the most affected by the development of the Internet of Things. Logic-fin's study confirms that this is becoming a reality: diagnosis of illnesses, support for doctors through the Internet of Things,...